论文部分内容阅读
葡萄糖酸亚铁Ferrous Gluconate是一种新型的防治缺铁性贫血药物。缺铁性贫血常见,发病率很高,严重影响人们的健康。目前我国抗缺铁性贫血药物的品种少,而且副作用大,吸收利用率较低,为填补国内空白,广西梧州制药厂1985年开始研制葡萄糖酸亚铁,1987年经卫生部审定批准生产,为广大缺铁性贫血患者提供了一种理想的药物。 [药理作用]葡萄糖亚铁主要作用于造血系统,铁元素作为机体生化过程中必须的物质,为造血提供原料,参与红细胞及血红蛋白等合成,消除因缺铁产生的贫血或缺铁引起的代谢紊乱。
Ferrous Gluconate Ferrous Gluconate is a new type of drug for preventing and treating iron deficiency anemia. Iron deficiency anemia is common, the incidence is high, seriously affecting people’s health. At present, there are few varieties of anti-iron-deficiency anemia drugs in our country with large side effects and low absorption and utilization rates. To fill the domestic blank, Guangxi Wuzhou Pharmaceutical Factory began to develop ferrous gluconate in 1985 and was approved by the Ministry of Health in 1987 to produce The majority of patients with iron deficiency anemia provides an ideal drug. [Pharmacological effects] Ferrous iron mainly acts on the hematopoietic system. As an essential substance in the biochemical process, iron is used as a raw material for hematopoiesis. It is involved in the synthesis of erythrocytes and hemoglobin, and eliminates metabolic disorders caused by anemia caused by iron deficiency or iron deficiency .